SKI Market

Indian Indices

Sensex

80,238.85 -1,048.34
( -1.29%)

Global Indices

Nasdaq

48,844.08 -676.12
(-1.37%)

Dow Jones

6,870.91 -58.95
(-0.85%)

Hang Seng

57,982.65 -867.62
(-1.47%)

Nikkei 225

10,926.32 79.62
(0.73%)

Forex

USD-INR

90.93 0.01
(0.01%)

EUR-INR

107.33 0.10
(0.10%)

GBP-INR

122.97 -0.01
(-0.01%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

BSE Select Business Groups

Industry : Stock Exchanges

BSE Code

ISIN Demat

Book Value()

1198

N.A

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

EPS(TTM)

Face Value()

Div & Yield %

100

Back

Mangalam Drugs and Organics reports consolidated net loss of Rs 9.84 crore in the December 2025 quarter

Jan 15,2026

Net loss of Mangalam Drugs and Organics reported to Rs 9.84 crore in the quarter ended December 2025 as against net profit of Rs 1.29 crore during the previous quarter ended December 2024. Sales declined 34.07% to Rs 58.38 crore in the quarter ended December 2025 as against Rs 88.55 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	58.38	88.55	-34
OPM %	-2.45	9.90	-
PBDT	-5.37	5.42	PL
PBT	-9.84	1.37	PL
NP	-9.84	1.29	PL

80,238.85 -1,048.34 ( -1.29%)

48,844.08 -676.12 (-1.37%)

6,870.91 -58.95 (-0.85%)

57,982.65 -867.62 (-1.47%)

10,926.32 79.62 (0.73%)

90.93 0.01 (0.01%)

107.33 0.10 (0.10%)

122.97 -0.01 (-0.01%)

0.58 0.00 (0.12%)